← All trials
NCT01063907
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2010
- Primary completion
- Nov 1, 2013
- Completion date
- Nov 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 95
- Arms / groups
- 5 / —
- Source
- AACT · pre-existing
Sponsors
- Kyowa Hakko KirinLead sponsor
- IQVIAStudy chair
- Gleneagles CRCStudy chair
- Kyowa Hakko KirinStudy director
- Kyowa Hakko KirinCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.